poisar

Stocks · News reference

Piper Sandler Maintains Overweight on Stryker, Lowers Price Target to $390

BenzingaJul 31, 2026, 2:52 PMBenzinga Newsdesk

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 31, 2026, 2:52 PM
Checked
Jul 31, 2026, 2:52 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncAug 25, 2026, 3:59 PMSns Insider

    Intravascular Lithotripsy Market Size to Reach USD 4.19 Billion by 2035 as Coronary and Peripheral IVL Adoption Accelerates – SNS Insider

    The global Intravascular Lithotripsy (IVL) market is projected to grow from USD 1.01 billion in 2025 to USD 4.19 billion by 2035, expanding at a 15.3% CAGR. Growth is driven by increasing prevalence of calcified coronary and peripheral artery disease, adoption of minimally invasive procedures, and expanding peripheral IVL applications. North America leads with 58% market share, while Asia-Pacific is the fastest-growing region.

    Read original at globenewswire-inc